US Corporate Board Director Changes SEC Filings — October 19, 2026

19-10-2026

American Clean Resources Group, Inc. (ACRG) appointed Anthony Evers as Fractional Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer effective October 19, 2026, replacing Tawana Bain as Interim Principal Financial Officer and Interim Principal Accounting Officer. Evers will serve under a consulting agreement with Satevers II LLC at $250 per hour (up to 60 billable hours per month), rising to $275 per hour from day 91 unless a fixed monthly retainer is agreed. The filing discloses no financial results and no negative or flat performance metrics.

• · Evers previously served as CFO and COO of SurgePays, Inc. from 2020, with that employment ending December 31, 2025, and provided consulting services to SurgePays through June 30, 2026
• · Evers' consulting services cover financial reporting, SEC filings, and transition assistance
• · The Consulting Agreement will be filed as an exhibit to the Form 10-K for fiscal year ending December 31, 2026
• · No family relationships, no selection arrangements, and no Item 404(a) related-party interest beyond the Consulting Agreement

19-10-2026

Astrotech Corporation (ASTC) approved on October 13, 2026 a Transaction Incentive Bonus Plan for its wholly-owned subsidiary 1st Detect Corporation, funding a bonus pool equal to 20% of net Sale Transaction proceeds, but only if transaction value reaches at least $20 million. The Board also approved a First Amendment removing the sale of a major subsidiary from the 'Qualifying Transaction' definition of the Company's existing Transaction Bonus Plan. No financial results or cash outlays are disclosed at this stage, and the filing contains no quantified performance comparisons.

• · Bonus payments are due on or within 30 days after Sale Transaction proceeds are received, and eligibility is forfeited on termination of employment or failure to timely return a release.
• · Unallocated pool amounts may be awarded to CEO Thomas B. Pickens III at the discretion of Tom Wilkinson, if Wilkinson remains an independent director and administrator at the time of a sale.
• · Award letters for both plans are filed as Exhibits 10.3 and 10.4; the amended Company plan is filed as Exhibit 10.2.

19-10-2026

Chord Energy provided preliminary 3Q26 operational and financial results, with volumes exceeding the high end of guidance across oil, natural gas and NGLs and CapEx in line with guidance, driving adjusted free cash flow above expectations. The company repurchased $205MM of shares in 3Q26 at an average of $135.74/share and another $44.3MM quarter-to-date in 4Q26, and announced the divestiture of non-operated Marcellus assets for $550MM gross consideration. Results are unaudited and the condensed consolidated financial statements are not yet available; the company also reported a $48.7MM loss on realized hedges in 3Q26.

• · Average realized commodity prices in 3Q26: NYMEX WTI averaged $85.69/Bbl and NYMEX Henry Hub averaged $2.96/MMBtu
• · Share repurchases averaged $135.74/share in 3Q26 and $142.32/share quarter-to-date in 4Q26
• · Preliminary 3Q26 financial data is unaudited and not reviewed by the independent auditor; actual results could differ materially
• · Marcellus-related CapEx exceeded internal expectations by about $6MM, partly offset by reimbursable non-op CapEx
• · Results compared against guidance released in August 2026

19-10-2026

Venu Holding Corporation (NYSE American: VENU) disclosed that President William Hodgson will cease serving as President effective October 13, 2026, remaining an employee until December 1, 2026 with severance payable over a 90-day period (final terms not yet determined); no successor has been named. The company also completed Aramark's additional $10,005,000 Series B Preferred equity investment on October 15, 2026, and reduced the principal of its $25,000,000 senior secured convertible debenture to $12,500,000 by applying the $12,500,000 holdback, which cut each remaining monthly installment principal from $5,000,000 to $2,500,000 and reduced the Investor Warrants from 1,000,000 to 500,000 shares and Placement Agent Warrants from 200,000 to 100,000 shares. The first installment of $2,875,000 was paid in cash on October 14, 2026.

• · Hodgson's departure was mutual and not the result of any disagreement on company policies or practices
• · No designated successor named; presidential responsibilities shifted to current management and recently added content procurement personnel
• · Holdback application was made because the company determined its financing needs no longer required the $12.5M, reducing debt service, payment premiums, and warrant dilution
• · Remaining installments are expected to be paid in cash on their due dates

19-10-2026

Tamboran Resources Corporation announced that Todd Abbott has been appointed Managing Director in addition to his existing role as Chief Executive Officer, effective October 19, 2026. The appointment formalizes his board-level leadership as the company moves from appraisal into development of the Beetaloo Basin, with first gas sales to the Northern Territory market achieved in recent months. The material terms of his appointment are unchanged from the ASX announcement of January 12, 2026.

• · Abbott was first appointed CEO in January 2026, and this filing formalizes his Board-level role as Managing Director
• · Tamboran achieved first gas sales from the Beetaloo to the Northern Territory gas market in the months preceding the announcement
• · Company guidance noted in forward-looking disclaimers: no material revenue expected until the second half of 2026, and going-concern doubt raised by recurring operating losses and negative cash flows

19-10-2026

Omnitek Engineering Corp. disclosed that directors Gary S. Maier and John M. Palumbo resigned from the board effective October 15, 2026. The company states the resignations were not due to any disagreement with the company, its board, attorneys, or auditors on matters relating to operations, policies, or practices. No replacement directors or new officer appointments were disclosed in this filing.

• · Filing reports board resignations effective October 15, 2026, while the filing itself is dated October 19, 2026
• · Company headquarters relocated from 1280 Activity Dr., Vista, California to 1501 N. Carlotte Avenue, Monroe, NC 28110
• · Company is a California corporation with Commission File Number 000-53955 and IRS Employer Identification No. 33-0984450
• · Securities are not registered under Section 12(b); trading symbol listed as N/A

19-10-2026

Nexentis Technologies Inc. (Nasdaq: NXTS) issued a total of approximately 922,188 shares of common stock on October 15, 2026, comprising grants under its 2022 Share Incentive Plan to the CEO (101,549 shares), CFO (51,000 shares), directors (208,639 shares in aggregate), and a consultant for accounting services (51,000 shares), plus 510,000 shares issued outside the Plan to consultants for financial, investor relations, and business development services. The issuances were made in reliance on the Section 4(a)(2) private placement exemption, and the filing reflects an equity-based compensation and consultant payment activity rather than a change in leadership.

• · Filing is dated October 19, 2026 and reports events effective October 15, 2026, under Items 3.02 and 5.02
• · Shares were issued in reliance on Section 4(a)(2) of the Securities Act of 1933 as transactions not involving a public offering
• · Company is an emerging growth company and common stock trades under symbol NXTS
• · Filing notes the registrant's principal executive offices are in Ness Ziona, Israel and the registrant is incorporated in Nevada

19-10-2026

Vaxart, Inc. (OTCQB: VXRT) appointed Vice Admiral Raquel "Rocky" C. Bono, M.D. (U.S. Navy, Ret.) to its Board of Directors on October 19, 2026, pursuant to a cooperation agreement with a group of stockholders entered into in July 2026. Dr. Bono will chair the Stockholder Engagement Committee and serve on the Nominating and Governance and Clinical and Regulatory Affairs Committees. The filing discloses no financial results, so no period-over-period performance metrics are reported.

• · Dr. Bono is a board-certified trauma surgeon who previously served as Director of the Defense Health Agency and as Director of Washington State's Pandemic Health System Response.
• · Dr. Bono currently serves on the board of Humana Inc. (NYSE: HUM) and is Managing Partner of NAVA Edge LLC.
• · Vaxart's Lead Independent Director described the company as making progress toward a series of value-inflection milestones.
• · Vaxart's stock is quoted on the OTCQB, not a major exchange.

19-10-2026

Torrid Holdings Inc. (NYSE: CURV) announced that Chief Financial Officer Paula Dempsey has resigned to pursue another opportunity, and she will remain in the role through mid-November 2026 to ensure a smooth transition. The company appointed Will Langley, former CFO of Belk (January 2020 to May 2025) with 20 years of experience at Belk, as Interim Chief Financial Officer effective October 28, 2026. The filing contains no quantitative financial results, so no performance metrics are reported.

• · Dempsey's departure is effective with service continuing through mid-November 2026.
• · Langley's interim appointment takes effect October 28, 2026, which leaves a gap between Dempsey's stated end date and his start date only if the transition overlaps; the filing does not specify whether the roles overlap.
• · Dempsey is credited with leading store optimization efforts and with disciplined capital allocation and expense management.
• · The filing states Dempsey resigned to pursue another opportunity, without naming the new employer.
• · The filing describes the appointment as interim, so a permanent CFO search is implied but not confirmed.

19-10-2026

Polomar Health Services, Inc. (PMHS) disclosed that directors Alexandra Peterson (Audit Committee) and Gabrielle Toledano (Compensation Committee) resigned effective October 14, 2026, with no disagreement cited. The Board reduced its size from five to three directors (George Hornig, George Caruolo, Gabriel Del Virginia) and has not yet decided whether to fill the vacancies or further reduce the Board.

• · Both resignations were notified to the Board on October 15, 2026, effective October 14, 2026.
• · Ms. Peterson's departure leaves the Audit Committee and Ms. Toledano's departure leaves the Compensation Committee without those members, raising committee composition questions.
• · The Company states neither resignation resulted from a disagreement on operations, policies, or practices.
• · The Company's principal executive office moved from Palm Harbor, FL to New York, NY (575 Lexington Avenue), with a current telephone area code of (727).

19-10-2026

Tempest Therapeutics (Nasdaq: TPST) appointed John W. Frederick to its board of directors, announced October 14, 2026 and filed under Item 5.02. Frederick brings more than three decades of finance, capital markets and operations experience, most recently as CFO of Skillsoft, and the company says his expertise will support disciplined capital deployment and its in vivo CAR-T development milestones. The filing contains no financial results or quantitative performance data, so no period-over-period comparison is possible.

• · Frederick previously served as Chief Financial Officer of Skillsoft, responsible for financial reporting, investor relations, capital markets and liquidity strategy
• · Frederick also served at Indigo Ag as CFO and Global Head of Carbon Commercial Operations, and as Chief Operating and Financial Officer of Snagajob
• · Frederick currently serves on the board of MutualOne Bank and has served on the board of SenSanna, Inc. since 2016
• · Frederick holds a B.A. in Economics from the University of Maryland
• · Filing includes Item 9.01 exhibits (press release Exhibit 99.1) and Item 7.01 Regulation FD disclosure

19-10-2026

Old Second Bancorp's Vice Chairman Gary Collins notified the company on October 14, 2026 of his decision to retire effective October 31, 2026, and will also resign from the boards of the Company and Old Second National Bank on his termination date. The retirement was not due to any disagreement with the company, and Mr. Collins has entered into a Separation and General Release Agreement providing approximately $211,150 in lump-sum cash payments, full vesting of unvested time-based RSUs, and pro-rata vesting (at target) of performance-based RSUs, subject to a release of claims.

• · Retirement effective October 31, 2026; Collins resigns from both boards upon termination of employment
• · Separation payments are conditional on execution and non-revocation of a release of claims
• · Full vesting of unvested time-based RSUs and pro-rata vesting at target of performance-based RSUs
• · Restrictive covenants in Collins' Executive Employment Agreement remain in effect
• · Full Separation Agreement to be filed as an exhibit to the Form 10-Q for the quarter ending September 30, 2026

19-10-2026

iBio, Inc. filed a Certificate of Amendment to its Certificate of Incorporation, executed October 16, 2026 by CEO and CSO Martin Brenner, restating the first sentence of Article Fourth to authorize 501,000,000 total shares of capital stock (500,000,000 common and 1,000,000 preferred, each at $0.001 par value). The amendment was approved by the Board and adopted by stockholders under DGCL Section 242 and becomes effective upon filing with the Delaware Secretary of State. The exhibit itself contains no details on the number of shares currently outstanding, the purpose of the increase, or any financing transaction, so its investor impact cannot be fully assessed from this document alone.

• · Amendment executed October 16, 2026, and effective upon filing with the Delaware Secretary of State
• · Approved by the Board of Directors and adopted by stockholders at a meeting under DGCL Section 242
• · Certificate of Incorporation history includes multiple prior amendments and preferred stock designations (Series A, B, C, and 2022 Convertible Preferred), with the most recent prior amendment filed November 28, 2023

19-10-2026

Once Upon a Farm, PBC (NYSE: OFRM) announced the appointment of Scott Morris, Co-Founder of Freshpet, to its Board of Directors effective immediately (October 19, 2026). Morris brings more than three decades of consumer packaged goods experience, including co-founding Freshpet in 2006 and building it into a category leader with more than $1 billion in annual sales. The filing is a board appointment press release with no financial results, guidance, or quantitative performance data disclosed.

• · Morris previously served as President, Chief Operating Officer and Chief Marketing Officer at Freshpet and was instrumental in building its in-store refrigerated network
• · Morris also served as Vice President of Marketing at The Meow Mix Company and spent more than a decade in sales and marketing leadership at Ralston Purina
• · Morris is an existing acquaintance of CEO John Foraker, per the company's statement

19-10-2026

Acadia Realty Trust (NYSE: AKR) appointed Tamara (Tammy) Fischer as a Trustee and to the Nominating and Corporate Governance Committee, effective October 19, 2026. Fischer brings three decades of REIT financial and executive experience, most recently as Executive Chairperson of National Storage Affiliates Trust until its acquisition by Public Storage in July 2026. The filing is a board appointment announcement with no reported financial results, dividend, or guidance changes.

• · Fischer joins the Nominating and Corporate Governance Committee in addition to the Board
• · Fischer currently sits on the boards of Mid-America Apartment Communities (since 2023, Audit and Real Estate Investment Committees) and JLL Income Property Trust (since 2023, chairs Audit Committee)
• · Fischer previously was CEO of National Storage Affiliates Trust (January 2020 – March 2023) and CFO of Chateau Communities (1993–2003)
• · Fischer is a certified public accountant (inactive) with a B.A. in Business Administration from Case Western Reserve University

19-10-2026

CarMax appointed Darren W. Woodell, currently Vice President and Controller at Genworth Financial, as Vice President, Controller and Chief Accounting Officer, effective November 11, 2026, succeeding Enrique N. Mayor-Mora as principal accounting officer; Mayor-Mora remains Executive Vice President and Chief Financial Officer. Woodell's offer package includes a $385,000 base salary, a $175,000 corporate bonus payable May 2027, a $100,000 sign-on bonus, and $330,000 in stock-settled RSUs vesting on the third anniversary of grant. The filing reports no financial results, so the news is a routine leadership transition with no reported negative or positive performance metrics.

• · Woodell has been Vice President and Controller (Principal Accounting Officer) at Genworth since February 2024, and has been with Genworth since 2010
• · Woodell is a licensed Certified Public Accountant in Virginia and Florida
• · Woodell's sign-on bonus and RSU grant are part of his offer letter terms
• · Woodell has no family relationships with directors or executive officers and no material related-party interest under Item 404(a)

19-10-2026

CRISPR Therapeutics AG announced that SVP, Finance Andrew J. Silver (age 42) has been promoted to Chief Financial Officer effective immediately, with a $515,000 base salary, a 45% target bonus, and a one-time grant of 25,000 RSUs vesting in full on the second anniversary of grant. Concurrently, CFO Raju Prasad, Ph.D. resigned to pursue external opportunities, stating no disagreement with the Company on financial statements, accounting, or controls, and is expected to remain employed through on or before November 30, 2026.

• · Silver joined CRISPR in October 2018 and previously spent over 10 years at Ernst & Young LLP as a Senior Manager in Assurance Services and is a CPA
• · Silver's employment agreement includes a 6-month notice period on termination without Cause or resignation for Good Reason, extended to 12 months if within 12 months after a Change in Control
• · Prasad's resignation is effective with employment continuing until on or before November 30, 2026, creating a transition window
• · Silver's 2026 bonus will be pro-rated to reflect the effective date of his promotion

19-10-2026

CDW Corporation announced the appointment of Sam Balaji to its Board of Directors, effective October 15, 2026. Balaji, former Global CEO of Consulting & Advisory at Deloitte, brings over three decades of experience in technology, advisory, and global business leadership. The announcement is a governance update with no disclosed financial results, guidance, or quantitative performance data.

• · Balaji currently serves on the board of BlackLine, a financial and accounting cloud software provider, bringing public company governance and cybersecurity oversight experience
• · CDW operates across business, government, education and healthcare sectors in the United States, United Kingdom and Canada

19-10-2026

Medtronic plc announced on October 15, 2026 the completion of the separation of MiniMed Group, Inc. (Nasdaq: MMED) via an exchange offer in which Medtronic exchanged its entire remaining stake of 252,813,348 MiniMed common shares for outstanding Medtronic ordinary shares. The exchange offer was 5.4x subscribed, and the separation is now complete, with Medtronic retaining no remaining interest in MiniMed. The filing is an 8-K whose Item 5.02 and 5.07 headings (officer/director change and shareholder vote) appear in the filing metadata, but the body text provided contains only the press release exhibit and does not describe any specific officer departure or vote result.

• · Exchange offer results were announced separately on October 14, 2026; the completion release confirms book-entry crediting of MiniMed shares and cash-in-lieu for fractional shares sold in the open market.
• · The separation is intended to be generally tax-free to shareholders for U.S. federal income tax purposes.
• · Goldman Sachs & Co. LLC and BofA Securities, Inc. served as dealer managers for the exchange offer.

19-10-2026

Professional Diversity Network, Inc. (IPDN) disclosed under Item 5.02 that director Shaikh Ali Sultan Al Nuaimi resigned from its Board of Directors, effective October 30, 2026, after notifying the Board on October 16, 2026. He had served as a director since November 2025, and the filing states the resignation was not due to any disagreement with the Company, its management, or the Board regarding operations, policies, or practices.

• · Resignation notice given to the Board on October 16, 2026; effective date October 30, 2026
• · Director had served since November 2025, so tenure was roughly 11 months
• · Filing explicitly states no disagreement with the Company, management, or Board

19-10-2026

Mineralys Therapeutics appointed Kristine Peterson and Lonnel Coats to its Board of Directors effective October 19, 2026, expanding the Board from seven to nine directors. Ms. Peterson joins the Audit Committee as a Class I director and Mr. Coats joins the Compensation Committee as a Class II director; both were granted equity awards under the non-employee director compensation program and entered into the standard indemnification agreement.

• · Ms. Peterson was appointed as a Class I director with a term expiring at the 2027 annual meeting and to the Audit Committee
• · Mr. Coats was appointed as a Class II director with a term expiring at the 2028 annual meeting and to the Compensation Committee
• · The Board determined both new directors meet Nasdaq independence requirements
• · Neither director has a Item 404(a) related-party transaction or selection arrangement requiring disclosure

19-10-2026

JELD-WEN announced that CFO Samantha L. Stoddard will resign effective November 13, 2026, to pursue an opportunity outside the building products industry. Jeffrey Embt, Vice President and Chief Accounting Officer, will concurrently serve as Interim CFO while keeping his current role, and the company will begin a search for a permanent CFO. The company reaffirmed its updated full-year 2026 guidance of $3.1 billion to $3.2 billion in revenue and $120 million to $150 million in Adjusted EBITDA, as previously announced on August 3, 2026.

• · Stoddard's departure is effective November 13, 2026, the same date Embt assumes the Interim CFO role
• · Embt joined JELD-WEN in January 2026 and previously served as CFO and Chief Accounting Officer of Proterra LLC
• · Stoddard had served the company for six years
• · Guidance is a reaffirmation of ranges first set on August 3, 2026, and excludes potential acquisitions or divestitures

19-10-2026

Lear Corporation announced a CFO succession plan under which Jared Fedele, currently Vice President of Finance for Seating and E-Systems, will become Senior Vice President and Chief Financial Officer effective March 1, 2027. Current CFO Jason Cardew, with 34 years of service, will remain CFO through February 28, 2027, then serve as non-executive Executive Advisor through December 31, 2027. The transition is presented as orderly and planned, with no financial results or performance metrics disclosed.

• · Fedele previously led Global Financial Planning and Analysis and held senior operational finance roles across Lear
• · Cardew will serve as non-executive Executive Advisor to senior management through December 31, 2027, supporting strategic matters
• · Fedele's Asia Pacific experience includes significant involvement supporting Lear's expansion in China
• · Ray Scott cited Fedele's role in leading the company's response to tariffs and profitability initiatives

19-10-2026

Matrix Service Company (Nasdaq: MTRX) announced the appointment of Dominic A. Savarino as Senior Vice President and Chief Financial Officer, effective November 6, 2026, reporting to President and CEO Shawn P. Payne. Savarino previously served as CFO of Diamond Offshore Drilling Inc. and held executive roles at McDermott International, Inc. The filing contains no quantitative financial results, so no period-over-period performance comparison is available.

• · Savarino will lead finance and accounting, including investor relations, treasury, tax, FP&A, and financial reporting
• · Savarino previously held VP and General Manager – Americas, VP Finance – Asia Pacific, and VP Tax roles at McDermott International
• · Savarino holds a BBA and Master of Professional Accounting from the University of Texas and is a Texas CPA
• · Matrix reports three segments: Storage and Terminal Solutions, Utility and Power Infrastructure, and Process and Industrial Facilities

19-10-2026

Home Bancorp reported Q3 2026 net income of $10.1 million, or $1.28 diluted EPS, down $1.5 million from $11.6 million ($1.48 EPS) in Q2 2026. Net interest income was essentially flat at $35.9 million, but net interest margin fell 5 basis points to 4.19%, and nonperforming assets rose 37% to $53.7 million (1.49% of total assets) after six loan relationships totaling $19.5 million moved to nonaccrual. Loans and deposits both declined slightly, and the company declared a $0.32 quarterly dividend.

• · Quarterly cash dividend of $0.32 per share declared, payable November 13, 2026 to holders of record as of November 2, 2026
• · Uninsured deposits declined to $933.7M from $959.4M in Q2 2026
• · Investment securities net unrealized loss widened to $36.5M from $25.0M, and the portfolio's effective duration lengthened to 3.6 years from 3.4 years
• · Construction and land loans fell 6% ($19.8M), while commercial and industrial loans grew 4% ($16.3M)
• · Core deposits fell $28.3M (1.2%) to $2.3B, and 97% of certificates of deposit ($729.4M) mature within 12 months
• · Tangible book value per share was $46.97 at September 30, 2026
• · Management states it does not anticipate sizable losses from the six nonaccrual relationships
• · Earnings conference call scheduled for October 20, 2026 at 10:30 a.m. CDT

19-10-2026

ProPetro Holding Corp. (NYSE: PUMP) announced the appointment of Kyle Crowley as an independent director of its Board of Directors, effective October 16, 2026. Crowley brings more than 30 years of power and energy experience, including 21 years at Exelon Corporation, where he led corporate development and executed more than 65 closed transactions with total equity value over $38 billion. The appointment is framed by management as supporting the growth of PROPWR, the company's gas-to-power division, though the release contains no quantitative financial results for the period.

• · Crowley served as SVP, Corporate Finance and Development at Exelon from October 2022 to June 2024, and previously as SVP and Chief Development Officer from December 2010 to October 2022
• · Crowley holds an MBA from the University of Chicago Booth School of Business and a BS in Finance from Indiana University
• · Crowley is a director of ONE Nuclear (NASDAQ: ONEN), serving on its Audit and Compensation Committees
• · Crowley is a director of Hennessy Capital Investment Corp. VIII (NASDAQ: HCIC)
• · Crowley's notable deals include the acquisition of Pepco Holdings, the acquisition of Constellation Energy, and the 2022 spin-off of Constellation Energy Corporation

19-10-2026

Ball Corporation announced leadership changes in two beverage packaging business units. Carey Causey was appointed SVP and President of Beverage Packaging North and Central America, effective immediately, succeeding Kathleen Pitre, and Scott Vail was named SVP and President of Beverage Packaging EMEA, succeeding Mandy Glew, who is retiring effective January 2027. The company states the departures are not related to any disagreement.

• · Causey joined Ball in 2014 and was president of Beverage Packaging EMEA from 2021 to 2024
• · Vail joined Ball in 2021 as VP, Operations, Beverage Packaging North and Central America, and was president of Metal Container Corporation before Ball
• · Glew's retirement is effective January 2027, while the North and Central America change takes effect immediately
• · Ball's leadership changes are described as reinforcing focus on disciplined execution across global packaging operations

19-10-2026

CytoDyn Inc. (OTCQB: CYDY) appointed Robert E. Hoffman as Chief Executive Officer effective October 20, 2026, succeeding Dr. Jacob Lalezari, who had served as CEO since November 2023. Dr. Lalezari remains with the company as Head of Research and Translational Sciences, focusing on new solid-tumor oncology opportunities for leronlimab. Mr. Hoffman, who first joined CytoDyn on May 15, 2025 as CFO, will also continue as principal accounting officer. The filing contains no quantitative financial results, so no performance comparisons are available.

• · Dr. Lalezari supports the transition and intends to continue supporting the Company's scientific efforts
• · Management describes 2027 as a year of clinical results, regulatory progress, and renewed partnering opportunities
• · Mr. Hoffman previously served as President, CEO, interim CFO and Chairperson at Kintara Therapeutics
• · Leronlimab is being pursued in colorectal cancer (mCRC) and metastatic triple-negative breast cancer (mTNBC)
• · Fiscal year ended May 31, 2026 10-K is referenced as the source of forward-looking risk disclosures

19-10-2026

Standex International Corporation (NYSE: SXI) announced that Samantha L. Stoddard, currently Executive Vice President and Chief Financial Officer of JELD-WEN Holding, Inc., will join as Vice President, Chief Financial Officer and Treasurer effective December 1, 2026, reporting to Chairman, President and CEO David Dunbar. She succeeds Ademir Sarcevic, who has served as CFO during the search and will remain in that role until Ms. Stoddard joins, after which he will focus on the Electronics segment and certain corporate projects. The filing contains no quantitative financial results, so no performance metrics are reported in either direction.

• · Ms. Stoddard has been EVP and CFO of JELD-WEN since July 2024 and joined JELD-WEN in 2020
• · Previously held roles at Honeywell, including CFO of the Personal Protection Equipment business unit
• · Holds a master's in accounting from The University of Texas at Dallas and a B.A. in economics and political science from Wake Forest University
• · Sarcevic was promoted to EVP – Corporate and Group President – Electronics in May 2026
• · Sarcevic remains CFO until December 1, 2026 to bridge the transition

19-10-2026

Mattel appointed Peter Griffith as Chief Financial Officer and Board director, effective October 20, 2026, succeeding Paul Ruh, who will serve in an advisory role through the end of 2026. Griffith previously served as EVP and CFO of Amgen and reports to Chairman and CEO Roger Lynch. The release contains no financial results or performance metrics, so the filing does not show whether Mattel's financial performance is improving or declining.

• · Griffith joined Amgen in 2019 from Sherwood Canyon Group, where he was President, after more than two decades as a partner at EY, where he was Global Vice Chair, Corporate Development.
• · At EY, as Global Managing Partner, Operations and Finance, Griffith oversaw a period in which annual revenue grew by more than 25% to over $27 billion.
• · Paul Ruh is credited with strengthening Mattel's Finance and Global Technology organizations and further reinforcing the balance sheet.
• · The release cites a prior material weakness in Mattel's internal control over financial reporting, which remediation controls are intended to address.

19-10-2026

Expand Energy Corporation (NASDAQ: EXE) appointed Daniel E. Brown as President and Chief Executive Officer effective October 26, 2026, and he will also join the Board. Michael A. Wichterich, Interim President and CEO since February 2026, returns to his role as Non-Executive Chairman. Brown previously led Chord Energy through a strategic portfolio transformation and spent nearly 20 years at Anadarko Petroleum.

• · Brown's appointment followed a comprehensive search led by the Board with a leading search firm, evaluating internal and external candidates
• · Company describes itself as the largest natural gas producer in the U.S. and North America's leading integrated natural gas company, reaching customers across the U.S. and Canada
• · Brown's prior role at Chord Energy was President, CEO and Board member (NASDAQ: CHRD)

19-10-2026

Williams-Sonoma, Inc. (NYSE: WSM) appointed Lynn Martin, current President of NYSE Group (a subsidiary of Intercontinental Exchange, Inc.), to its Board of Directors on October 19, 2026. The announcement is a board-level governance addition with no reported financial results, guidance, or quantitative performance data. The tone of the release is positive and forward-looking, emphasizing Martin's expertise in data, technology, risk management, and corporate governance.

• · Martin previously served as President of Fixed Income & Data Services at ICE and President of ICE Data Services
• · Martin also chairs ICE Fixed Income & Data Services and oversees NYSE's equities and options exchanges
• · Williams-Sonoma operates in the U.S., Puerto Rico, Canada, Australia, and the United Kingdom, with unaffiliated franchisees in Mexico, South Korea, India, and the Philippines
• · Williams-Sonoma is described as a Fortune 500 and S&P 500 company

19-10-2026

BNB Standard Corporation (Nasdaq: BNC) launched a new corporate website at www.bnbstandard.com featuring an expanded treasury dashboard that publishes Adjusted NAV and Adjusted NAV per share (non-GAAP measures) updated intraday, along with an investor relations hub, BNB ecosystem education resources, and a brand media kit. The company also designated its website and X account as channels for Regulation FD disclosure. The release quotes Alex Odagiu as Interim President and Brent Miller as Interim Principal Executive Officer and CFO, and its forward-looking statements flag risks including the outcome of litigation over the Asset Management Agreement, unpaid accrued management fees, collateral maintenance obligations under a master loan facility, a material weakness in internal control over financial reporting, and deadlines to appoint a permanent CEO and an additional independent director under a cooperation agreement with YZiLabs.

• · Company intends to use its website (www.bnbstandard.com) and X account (@BNBStandardCo) as Regulation FD disclosure channels
• · Dashboard snapshots of figures are recorded at 4:30 p.m. ET each trading day; BNC prices outside U.S. market hours use the most recent closing price
• · Pending risks include litigation over the Asset Management Agreement and non-payment of accrued management fees
• · Deadlines exist to appoint a permanent CEO and an additional independent director under the YZiLabs cooperation agreement
• · A previously disclosed material weakness in internal control over financial reporting remains outstanding

19-10-2026

NRC Health (NASDAQ: NRC) disclosed that on October 14, 2026, its board designated Chief Executive Officer Trent Green to also serve as interim principal financial officer, with no compensation changes tied to the appointment. The filing provides Green's biographical background, including prior leadership roles at Amazon One Medical and Legacy Health, and states no related-party transactions or arrangements were involved. No financial results or quantitative performance data are reported in this filing.

• · Trent Green has served as CEO since June 2025
• · Green was CEO of Amazon One Medical from September 2023 to February 2025 and COO from July 2022 to August 2023
• · Prior roles at Legacy Health included SVP and COO (2019-2022), President of Emanuel Medical Center (2017-2019), and SVP and Chief Strategy Officer (2008-2017)
• · Green was a management consultant at Tiber Group/Navigant Consulting (now Guidehouse) from 1999 to 2008
• · No compensation changes accompany the interim CFO designation
• · Green has no material interest in any Item 404(a) related-person transaction

19-10-2026

Elventix Technology Corporation appointed Fernando Martins Jose Maria to its Board of Directors, effective October 19, 2026, to serve until the next annual meeting or until his successor is elected. The filing discloses his background as a former Lead Software Architect at Softplan (April 2024 to March 2026) and as an independent software developer and technical consultant since October 2019. No compensation, related-party transactions, or family relationships were disclosed.

• · Mr. Martins Jose Maria holds a Bachelor's degree in Computer Science from the University of Sao Paulo (December 2021)
• · Company is an emerging growth company; its Section 12(b) securities are listed as 'None', indicating no exchange-registered securities
• · Company disclosed no arrangements or understandings with other persons for his selection, no family relationships, and no reportable Item 404(a) transactions

19-10-2026

Zedge, Inc. (NYSE American: ZDGE) disclosed that Jonathan Reich, who ceased serving as CEO effective September 30, 2026, became President and Chief Operating Officer effective October 1, 2026. He entered a three-year employment agreement (through September 30, 2029) with a base salary of $390,000, a minimum annual bonus of $124,313, and an equity award of 100,000 Class B shares to be granted within 150 days. The filing contains no performance results, so the tone is neutral to slightly mixed given the leadership transition.

• · Reich's prior CEO departure was previously disclosed in an 8-K filed August 31, 2026
• · Separation pay includes up to two years of base salary plus a prorated minimum bonus, with full equity acceleration on termination without Cause or resignation for Good Reason
• · Reich reports directly to the CEO and works from a home office in New Jersey
• · Employment agreement is dated October 14, 2026 and filed as Exhibit 10.1